Full transparency, $CLOV has held my attention since May. I currently own 7700 shares and over 800 Calls with varying strikes at 4, 2.5, 2, and 1.5 between this Friday and May. I also have a handful of Jan 20 '23 $15 Calls. Clover Health remains my top interest stock.
Last week's Q4 Reporting, for me, validated everything I have come to believe about this company:
1.) They're growing. Rapidly. Intelligently.
2.) They've improved their upside down MCR and revealed credible plans going forward to drop MCR to 90%.
3.) They revealed plans for cutting costs combined with expansion in 2022 to put them on track for profitability in 2023 if not 2022.
4.) The dilution of their offering in November was perfectly timed to provide for 2022's expansion without need for another offering.
5.) Their current share price now gives them a Market Cap lower than Revenue. Opportunities like this in great companies don't appear very often.
I'm amazed at the negativity directed at Clover Health online. But, the solid investors give advice to buy when others are selling. With Clover Health, that's exactly what I'm doing.
This post is my opinion only, and not financial advice. Please do your due diligence.
Are you in $CLOV? Show your support with a comment below.
Leave a Reply